Showing results (861-870 of 2,106) with videos related to
Sort By:
Pageof 211
CNS Drugs|June 1, 2012
Pharmacotherapy for parents with attention-deficit hyperactivity disorder (ADHD): impact on maternal ADHD and parentingAndrea Chronis-Tuscano, Mark A SteinCNS Drugs|October 12, 2013
Second generation antipsychotic-induced type 2 diabetes: a role for the muscarinic M3 receptorKatrina Weston-Green, Xu-Feng Huang, Chao DengCNS Drugs|August 28, 2014
Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapyYusuke Ogawa, Aran Tajika, Nozomi Takeshima, et al.CNS Drugs|September 4, 2014
Long-term (1 year) safety and efficacy of methylphenidate modified-release long-acting formulation (MPH-LA) in adults with attention-deficit hyperactivity disorder: a 26-week, flexible-dose, open-label extension to a 40-week, double-blind, randomised, placebo-controlled core studyY Ginsberg, T Arngrim, A Philipsen, et al.CNS Drugs|December 21, 2013
The pharmacology of imepitoin: the first partial benzodiazepine receptor agonist developed for the treatment of epilepsyChris Rundfeldt, Wolfgang LöscherCNS Drugs|July 6, 2014
Sodium oxybate in the treatment of alcohol withdrawal syndrome: a randomized double-blind comparative study versus oxazepam. The GATE 1 trialFabio Caputo, Katrin Skala, Antonio Mirijello, et al.CNS Drugs|August 29, 2015
Pharmacological Management of Opioid Use Disorder in Pregnant WomenChristine M Wilder, Theresa WinhusenCNS Drugs|August 16, 2017
Idarucizumab in Dabigatran-Treated Patients with Acute Ischemic Stroke Receiving Alteplase: A Systematic Review of the Available EvidenceSlaven Pikija, Laszlo K Sztriha, J Sebastian Mutzenbach, et al.CNS Drugs|July 11, 2016
Therapeutic Potential of Genipin in Central Neurodegenerative DiseasesYanwei Li, Lin Li, Christian HölscherCNS Drugs|May 26, 2016
A Review of Treatment Options for Progressive Supranuclear PalsyMaria Stamelou, Günter HöglingerPageof 211